Cost Study of a Cluster Randomized Trial on a Clinical Decision Rule Guiding Antibiotic Treatment in Children With Suspected Lower Respiratory Tract Infections in the Emergency Department.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
16
6
2021
Statut:
ppublish
Résumé
Children with fever and respiratory symptoms represent a large patient group at the emergency department (ED). A decision rule-based treatment strategy improved targeting of antibiotics in these children in a recent clinical trial. This study aims to evaluate the impact of the decision rule on healthcare and societal costs, and to describe costs of children with suspected lower respiratory tract infections (RTIs) in the ED in general. In a stepped-wedge, cluster randomized trial, we collected cost data of children 1 month to 5 years of age with fever and cough/dyspnea in 8 EDs in The Netherlands (2016-2018). We calculated medical costs and societal costs per patient, during usual care (n = 597), and when antibiotic prescription was guided by the decision rule (n = 402). We calculated cost-of-illness of this patient group and estimated their annual costs at national level. The cost-of-illness of children under 5 years with suspected lower RTIs in the ED was on average &OV0556;2130 per patient. At population level this is &OV0556;15 million per year in The Netherlands (&OV0556;1.7 million/100,000 children under 5). Mean costs per patient in usual care (&OV0556;2300) were reduced to &OV0556;1870 in the intervention phase (P = 0.01). Main cost drivers were hospitalization and lost parental workdays. Implementation of a decision rule-based treatment strategy in children with suspected lower RTI was cost-saving, due to a reduction in hospitalization and parental absenteeism. Given the high frequency of this disease in children, the decision rule has the potential to result in a considerable cost reduction at population level.
Sections du résumé
BACKGROUND
Children with fever and respiratory symptoms represent a large patient group at the emergency department (ED). A decision rule-based treatment strategy improved targeting of antibiotics in these children in a recent clinical trial. This study aims to evaluate the impact of the decision rule on healthcare and societal costs, and to describe costs of children with suspected lower respiratory tract infections (RTIs) in the ED in general.
METHODS
In a stepped-wedge, cluster randomized trial, we collected cost data of children 1 month to 5 years of age with fever and cough/dyspnea in 8 EDs in The Netherlands (2016-2018). We calculated medical costs and societal costs per patient, during usual care (n = 597), and when antibiotic prescription was guided by the decision rule (n = 402). We calculated cost-of-illness of this patient group and estimated their annual costs at national level.
RESULTS
The cost-of-illness of children under 5 years with suspected lower RTIs in the ED was on average &OV0556;2130 per patient. At population level this is &OV0556;15 million per year in The Netherlands (&OV0556;1.7 million/100,000 children under 5). Mean costs per patient in usual care (&OV0556;2300) were reduced to &OV0556;1870 in the intervention phase (P = 0.01). Main cost drivers were hospitalization and lost parental workdays.
CONCLUSIONS
Implementation of a decision rule-based treatment strategy in children with suspected lower RTI was cost-saving, due to a reduction in hospitalization and parental absenteeism. Given the high frequency of this disease in children, the decision rule has the potential to result in a considerable cost reduction at population level.
Identifiants
pubmed: 33075037
doi: 10.1097/INF.0000000000002794
pii: 00006454-202011000-00014
doi:
Substances chimiques
Anti-Bacterial Agents
0
Banques de données
NTR
['NTR5326']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1026-1031Références
Alpern ER, Stanley RM, Gorelick MH, et al.; Pediatric Emergency Care Applied Research Network. Epidemiology of a pediatric emergency medicine research network: the PECARN core data project. Pediatr Emerg Care. 2006; 22:689–699
Rozenbaum MH, Mangen MJ, Huijts SM, et al. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis. Vaccine. 2015; 33:3193–3199
Hasegawa K, Tsugawa Y, Cohen A, et al. Infectious disease-related emergency department visits among children in the US. Pediatr Infect Dis J. 2015; 34:681–685
Sinha A, Levine O, Knoll MD, et al. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet. 2007; 369:389–396
Miedema CJ, Kors AW, Tjon A Ten WE, et al. Medical consumption and socioeconomic effects of infection with respiratory syncytial virus in The Netherlands. Pediatr Infect Dis J. 2001; 20:160–163
Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006; 118:2418–2423
Brotons P, Gelabert G, Launes C, et al. Cost of hospitalizing children with invasive pneumococcal pneumonia. Vaccine. 2013; 31:1117–1122
Ehlken B, Ihorst G, Lippert B, et al.; PRIDE Study Group. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr. 2005; 164:607–615
Nijman RG, Vergouwe Y, Thompson M, et al. Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study. BMJ. 2013; 346:f1706
van de Maat JS, Peeters D, Nieboer D, et al. Evaluation of a clinical decision rule to guide antibiotic prescription in children with suspected lower respiratory tract infection in The Netherlands: a stepped-wedge cluster randomised trial. PLoS Med. 2020; 17:e1003034
Nederlandse Vereniging voor Kindergeneeskunde. Richtlijn Koorts in de tweede lijn bij kinderen van 0 - 16 jaar 2013. Available at: https://www.nvk.nl/Portals/0/richtlijnen/koorts/koortsrichtlijn.pdf. Accessed July 01, 2019
Zorginstituut Nederland. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. 2015
Zorginstituut Nederland. Medicijnkosten. Available at: www.medicijnkosten.nl. Accessed October10, 2019
Centraal Bureau voor de Statiek. Monitor loonverschillen mannen en vrouwen, 2016 2018. Available at: https://www.cbs.nl/nl-nl/maatwerk/2018/47/monitor-loonverschillen-mannen-en-vrouwen-2016. Accessed March 12, 2019
RIVM: Bilthoven. Volksgezondheidenzorg.info. Available at: https://www.volksgezondheidenzorg.info/onderwerp/acute-zorg/cijfers-context/gebruik-acute-zorg#!node-gebruik-seh. Accessed July 10, 2019, 2019
Centraal Bureau voor de Statiek. Bevolkingspiramide 2019. Available at: https://www.cbs.nl/nl-nl/visualisaties/bevolkingspiramide. Accessed Auguest 13, 2019
Keitel K, Alcoba G, Lacroix L, et al. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. Swiss Med Wkly. 2014; 144:w13925
Garcia-Marcos L, Valverde-Molina J, Pavlovic-Nesic S, et al.; BCOST group. Pediatricians’ attitudes and costs of bronchiolitis in the emergency department: a prospective multicentre study. Pediatr Pulmonol. 2014; 49:1011–1019
Rietveld E, De Jonge HC, Polder JJ, et al. Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk. Pediatr Infect Dis J. 2004; 23:523–529
van de Maat J, van de Voort E, Mintegi S, et al. Antibiotic prescription for febrile children in European emergency departments: a cross-sectional, observational study. Lancet Infect Dis. 2019; 19:384–391
Bressan S, Titomanlio L, Gomez B, et al.; REPEM. Research priorities for European Paediatric Emergency Medicine. Arch Dis Child. 2019; 104:869–873
Florin TA, French B, Zorc JJ, et al. Variation in emergency department diagnostic testing and disposition outcomes in pneumonia. Pediatrics. 2013; 132:237–244
Green CA, Yeates D, Goldacre A, et al. Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma. Arch Dis Child. 2016; 101:140–146
Leigh S, Grant A, Murray N, et al. The cost of diagnostic uncertainty: a prospective economic analysis of febrile children attending an NHS emergency department. BMC Med. 2019; 17:48
Irwin AD, Wickenden J, Le Doare K, et al. Supporting decisions to increase the safe discharge of children with febrile illness from the emergency department: a systematic review and meta-analysis. Arch Dis Child. 2016; 101:259–266
Higgins D, Trujillo C, Keech C. Advances in RSV vaccine research and development - A global agenda. Vaccine. 2016; 34:2870–2875